An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
Pharmacology effect
inhibítory vychytávania dopamínu
Pharmacology effect
Dopamine Uptake Inhibitors
subject heading
openseadragon
Number of the records: 1
This site uses cookies to make them easier to browse. Learn more about
how we use cookies.
